SCHEMBL30690658

SCHEMBL30690658

Cc1ncc(NC(=O)CC2CCCC2)cc1NC(=O)c1cnc2c(c1)cc(-c1cnn(C)c1)n2COCC[Si](C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 3/20 0.40
KIT P10721 1/20 0.40
NAMPT P43490 1/20 0.39
PDGFRA P16234 3/20 0.36
CHRM1 P11229 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
PDGFRB P09619 2/20 0.36
FLT3 P36888 1/20 0.36
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
TAS2R8 Q9NYW2 1/20 0.33
GSK3B P49841 4/20 0.33
DYRK1A Q13627 4/20 0.33
DGAT1 O75907 2/20 0.32
ABL1 P00519 1/20 0.32
WNT1 P04628 3/20 0.32
HDAC3 O15379 2/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC2 Q92769 2/20 0.32
PIK3C2G O75747 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30690775 0.92 CSF1R (0.37) CSF1RKITNAMPTPDGFRACHRM1
SCHEMBL30690760 0.90 CSF1R (0.40) CSF1RKITPDGFRACHRM1HRH3
SCHEMBL30690774 0.88 GSK3B (0.41) CSF1RKITPDGFRACHRM1HRH3
SCHEMBL30690797 0.88 GSK3B (0.44) CSF1RKITPDGFRACHRM1HRH3
SCHEMBL30690685 0.87 PDGFRA (0.42) CSF1RKITPDGFRACHRM1HRH3
SCHEMBL30690691 0.87 AURKB (0.37) CSF1RKITPDGFRACHRM1HRH3
SCHEMBL30690769 0.86 GSK3B (0.39) CSF1RKITPDGFRACHRM1HRH3
SCHEMBL30690642 0.86 CSF1R (0.41) CSF1RKITPDGFRACHRM1HRH3
SCHEMBL30690679 0.85 PDGFRA (0.40) CSF1RKITPDGFRACHRM1HRH3
SCHEMBL30690781 0.84 PDGFRA (0.39) CSF1RKITPDGFRACHRM1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247593-A1 PYRROLOPYRIDINE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 WO disclosed